Permanent Supportive Housing Overdose Prevention

Status Enrolling by invitation

Clinical Trial Summary

Permanent supportive housing (PSH), the gold standard intervention for ending chronic homelessness, has expanded rapidly across the U.S. in recent years. Due to a confluence of individual and environmental risk factors, PSH tenants face heightened risk for overdose. While evidence-based practices to prevent overdose exist, they have not been broadly implemented in PSH settings. This study will address this research to practice gap by studying the implementation of evidence-based practices to prevent overdose in 20 PSH buildings in New York. In a community-partnered stepped wedge randomized controlled trial, the investigators will study a package of implementation strategies that includes an implementation toolkit, tenant and staff implementation champions, limited practice facilitation, and learning collaboratives. Outcomes will be examined using surveys and qualitative interviews with PSH tenants and staff; observation; and analysis of Medicaid claims data.

Clinical Trial Description

This single-center study is a hybrid type 3 trial with a stepped wedge cluster randomized controlled trial design, with primary objectives of studying implementation of overdose prevention practices in PSH and secondary objectives of examining effectiveness on clinically relevant outcomes and multilevel factors influencing implementation. Twenty participating PSH building sites will be randomized into four intervention clusters of five buildings each. With the stepped wedge design, all clusters of study PSH buildings will begin in the control condition. Clusters are randomly assigned to receive the intervention at different times, with all eventually receiving the six-month implementation strategy package intervention from Corporation for Supportive Housing (CSH). Study investigators will survey PSH building tenants and staff; conduct observation of building policies and procedures; analyze tenant Medicaid data; and interview staff and tenants. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05786222
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	September 26, 2023
Completion date	January 31, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT01050270` - Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP)	Phase 4
Recruiting	`NCT05343169` - Community-based Education, Navigation, and Support Intervention for Military Veterans	N/A
Completed	`NCT03482232` - Consequences of Doing What Should Not be Done in Primary Care
Completed	`NCT03402672` - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users	N/A
Completed	`NCT03337100` - The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy	N/A
Enrolling by invitation	`NCT05776823` - Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)	N/A
Not yet recruiting	`NCT06316739` - The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City	N/A
Completed	`NCT03107689` - Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
Completed	`NCT02101424` - Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department	N/A
Completed	`NCT03518021` - Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital	Phase 3
Not yet recruiting	`NCT06236087` - Overdose Prevention Centers and Behavioral Health
Completed	`NCT04212364` - An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses	N/A
Completed	`NCT04953338` - Mental Health Associations With Vitiligo
Active, not recruiting	`NCT06456294` - Evaluation of a Medication Health Center to Promote Opioid Safety	N/A
Completed	`NCT03908437` - Rapid Initiation of Drug Treatment Engagement	Phase 4
Recruiting	`NCT05886712` - Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs (SAIA-Naloxone)	N/A
Completed	`NCT04797221` - Emergency Room Firearm and Medication Safety Intervention
Recruiting	`NCT06216327` - Safety Planning 6+	N/A
Completed	`NCT06219967` - Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting Efficacy	Phase 4

Permanent Supportive Housing Overdose Prevention — POP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms